Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1456 AL 1470

'Fly-ing' from rare to common neurodegenerative disease mechanisms

Ma M, Moulton MJ, Lu S, Bellen HJ.

Trends Genet. 2022 Sep;38(9):972-984. doi: 10.1016/j.tig.2022.03.018. Epub 2022 Apr 25.

The meningeal lymphatic vessels and the glymphatic system: Potential therapeutic targets in neurological disorders

Li G, Cao Y, Tang X, Huang J, Cai L, Zhou L.

J Cereb Blood Flow Metab. 2022 Aug;42(8):1364-1382. doi: 10.1177/0271678X221098145. Epub 2022 Apr 28.

Improvement of poststroke cognitive impairment by intermittent theta bursts: A double-blind randomized controlled trial

Li W, Wen Q, Xie YH, Hu AL, Wu Q, Wang YX.

Brain Behav. 2022 Jun;12(6):e2569. doi: 10.1002/brb3.2569. Epub 2022 Apr 29.

Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus

Kabir MT, Ferdous Mitu J, Akter R, Akhtar MF, Saleem A, Al-Harrasi A, Bhatia S, Rahman MS, Damiri F, Berrada M, Rahman MH.

Environ Sci Pollut Res Int. 2022 Jul;29(31):46385-46404. doi: 10.1007/s11356-022-20445-1. Epub 2022 Apr 29.

Combined effects of virtual reality techniques and motor imagery on balance, motor function and activities of daily living in patients with Parkinson's disease: a randomized controlled trial

Kashif M, Ahmad A, Bandpei MAM, Gilani SA, Hanif A, Iram H.

BMC Geriatr. 2022 Apr 30;22(1):381. doi: 10.1186/s12877-022-03035-1.

Pressure ulcer induced by discontinuation of levodopa: Case report of an older patient with Parkinson's disease

Kato M, Mizokami F, Takeda A, Matsumoto H, Isogai Z.

J Tissue Viability. 2022 Aug;31(3):557-559. doi: 10.1016/j.jtv.2022.04.002. Epub 2022 Apr 18.

Stepping up to meet the challenge of freezing of gait in Parkinson's disease

Lewis S, Factor S, Giladi N, Nieuwboer A, Nutt J, Hallett M.

Transl Neurodegener. 2022 May 1;11(1):23. doi: 10.1186/s40035-022-00298-x.

Biomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects

Blanc F, Bousiges O.

Rev Neurol (Paris). 2022 May;178(5):472-483. doi: 10.1016/j.neurol.2022.03.008. Epub 2022 Apr 28.

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Rodriguez-Porcel F, Wyman-Chick KA, Abdelnour Ruiz C, Toledo JB, Ferreira D, Urwyler P, Weil RS, Kane J, Pilotto A, Rongve A, Boeve B, Taylor JP, McKeith I, Aarsland D, Lewis SJG; Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+.

Transl Neurodegener. 2022 May 2;11(1):24. doi: 10.1186/s40035-022-00299-w.

A Randomized, Double-Blinded Crossover Trial of Short Versus Conventional Pulse Width Subthalamic Deep Brain Stimulation in Parkinson's Disease

Petry-Schmelzer JN, Gerus L, Jergas H, Reker P, Steffen JK, Dafsari HS, Baldermann JC, Fink GR, Visser-Vandewalle V, Dembek TA, Barbe MT.

J Parkinsons Dis. 2022;12(5):1497-1505. doi: 10.3233/JPD-213119.

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?

Sidoroff V, Bower P, Stefanova N, Fanciulli A, Stankovic I, Poewe W, Seppi K, Wenning GK, Krismer F.

J Parkinsons Dis. 2022;12(5):1369-1387. doi: 10.3233/JPD-223183.

Frequency of Depressive Disorders in Parkinson's Disease: A Systematic Review and Meta-Analysis

Chendo I, Silva C, Duarte GS, Prada L, Vian J, Quintão A, Voon V, Ferreira JJ.

J Parkinsons Dis. 2022;12(5):1409-1418. doi: 10.3233/JPD-223207.

Effects of Rhythmic Auditory Stimulation on Gait and Motor Function in Parkinson's Disease: A Systematic Review and Meta-Analysis of Clinical Randomized Controlled Studies

Wang L, Peng JL, Ou-Yang JB, Gan L, Zeng S, Wang HY, Zuo GC, Qiu L.

Front Neurol. 2022 Apr 15;13:818559. doi: 10.3389/fneur.2022.818559. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias